Literature DB >> 12790156

Brand versus generic medications: the money, the patient and the research.

Pierre Blier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12790156      PMCID： PMC161740     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  2 in total

1.  Eosinophilia-myalgia syndrome: mortality data from the US national surveillance system.

Authors:  L A Swygert; E E Back; S B Auerbach; L E Sewell; H Falk
Journal:  J Rheumatol       Date:  1993-10       Impact factor: 4.666

2.  The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina.

Authors:  E A Sullivan; M L Kamb; J L Jones; P Meyer; R M Philen; H Falk; T Sinks
Journal:  Arch Intern Med       Date:  1996-05-13
  2 in total
  3 in total

1.  Generic formulations of psychotropic medications and treatment response.

Authors:  Venkat Bhat; Howard C Margolese
Journal:  J Psychiatry Neurosci       Date:  2017-03       Impact factor: 6.186

2.  Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations.

Authors:  Mladena Lalic; Ana Pilipovic; Svetlana Golocorbin-Kon; Ksenija Gebauer-Bukurov; Ksenija Bozic; Momir Mikov; Jelena Cvejic
Journal:  Drugs R D       Date:  2011

Review 3.  Potential Clinical and Economic Impact of Switching Branded Medications to Generics.

Authors:  Robert J Straka; Denis J Keohane; Larry Z Liu
Journal:  Am J Ther       Date:  2017-05       Impact factor: 2.688
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.